0
0

Department of Veterans Affairs Awarded a Contract to AMGEN USA INC for $15,375,050.00

Signed on

9/2/2025, 12:00 AM

AMGEN USA INC Government Contract #36E79725D0053

AMGEN USA INC was awarded a contract with the United States Government for $15,375,050.00. The contract was awarded by the agency office NAC PHARMACEUTICALS (36E797), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.

Summary of Award

AMGEN USA INC, a U.S.-owned pharmaceutical manufacturer, received a contract from the Department of Veterans Affairs worth $15,375,050 for Trastuzumab. The contract is for drugs and biologicals with an ordering period from November 15, 2025, to November 14, 2026. The only transaction listed has a $0 transaction amount on September 2, 2025.

Contract Details

Contract ID36E79725D0053
Contract TypeIDV_B_A
Total Obligation$0.00
Exercised Options
Base Amount + Options$15,375,050.00
Date Signed2025-09-02
Contract DescriptionNEW AWARD FOR TRASTUZUMAB WITH AMGEN. ORDERING PERIOD IS NOV 15, 2025 THROUGH NOV 14, 2026 WITH FOUR ONE-YEAR OPTIONS.
Start Date2025-11-15
End Date2026-11-14

Agency Details

Awarding AgencyDepartment of Veterans Affairs
Awarding Sub AgencyDepartment of Veterans Affairs
Awarding OfficeNAC PHARMACEUTICALS (36E797)
Funding AgencyDepartment of Veterans Affairs
Funding Sub AgencyDepartment of Veterans Affairs
Funding OfficeNAC PHARMACEUTICALS (36E797)

Recipient Details

RecipientAMGEN USA INC
Recipient Location1 AMGEN CENTER DR NEWBURY PARK CALIFORNIA, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions

Transaction #0$0.00September 2, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $0.00 to AMGEN USA INC. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #P00001$0.00November 20, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $0.00 to AMGEN USA INC. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #0$0.00September 2, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $0.00 to AMGEN USA INC. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #P00002$0.00January 8, 2026

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $0.00 to AMGEN USA INC. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #P00001$0.00November 20, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $0.00 to AMGEN USA INC. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #0$0.00September 2, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $0.00 to AMGEN USA INC. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #P00003$0.00January 20, 2026

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $0.00 to AMGEN USA INC. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #P00002$0.00January 8, 2026

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $0.00 to AMGEN USA INC. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #P00001$0.00November 20, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $0.00 to AMGEN USA INC. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #0$0.00September 2, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $0.00 to AMGEN USA INC. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Latest Bills

Small Business Innovation and Economic Security Act
Bill S 3971March 10, 2026
Directing the President, pursuant to section 5(c) of the War Powers Resolution, to remove the United States Armed Forces from hostilities against the Islamic Republic of Iran.
Bill HCONRES 75March 10, 2026
Directing the Committee on Ethics to preserve and publicly release records of the Committee's review of violations or alleged violations of clause 9 (as it pertains to acts of sexual harassment) and clause 18 of rule XXIII of the Rules of the House of Representatives.
Bill HRES 1100March 10, 2026
To amend title 11, District of Columbia Official Code, to provide that grand and petit jurors serving in the Superior Court of the District of Columbia shall receive fees and expenses at the same rates paid to grand and petit jurors appearing in the district courts of the United States.
Bill HR 7881March 10, 2026
A resolution honoring the life and legacy of Reverend Jesse Louis Jackson, Sr., and commending him for his significant leadership during the Civil Rights Movement and his decades of advocacy in pursuit of justice, equality, and human rights.
Bill SRES 629March 10, 2026
Department of Homeland Security Appropriations Act, 2026
Bill HR 7744March 10, 2026
Veterans Accessibility Advisory Committee Act of 2025
Bill S 1383March 10, 2026
Taiwan Allies Fund Act
Bill S 1216March 10, 2026
Directing the President pursuant to section 5(c) of the War Powers Resolution to remove United States Armed Forces from unauthorized hostilities in the Islamic Republic of Iran.
Bill HCONRES 38March 10, 2026
Housing for the 21st Century Act
Bill HR 6644March 10, 2026